Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

The Etcamah results came a week after the U.S. granted approval for the drug for advanced breast cancer upon the detection of a specific mutation.

AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial

We haven't written up this one. Hindustan Times - World News has the full story — the link below goes straight to it.

Read the original at hindustantimes.com →

More in Health & Medicine

More from Monday 14 September →